BB Biotech (SWX:BION) has continued to show a resilient performance this year, a period that has proved to be extremely challenging for biotech investing – indeed the sector is now considered to be experiencing its most severe bear market for more than two decades. BB Biotech’s shares closed on Friday at CHF 56.00, down 23% […]
Oakley Capital Investments Limited (OCI) has announced that the Oakley Capital Origin Fund is investing in Vice Sporting Goods GmbH (Vice Golf), which OCI describes as the leading digitally native golf brand. OCI’s indirect contribution via the Origin Fund will be around £11m and its liquid resources available for future deployment (including this transaction) are […]
In QuotedData’s morning briefing 6 May 2022: Round Hill Music Royalty Fund (RHM) has announced the conversion ratio that is to be used to convert its C Shares into new ordinary shares, which is based on the respective unaudited estimated economic net asset values of the ordinary share pool and the C share pool calculated […]
In QuotedData’s morning briefing 22 April 2022: Asia Dragon (DGN) has published its interim results for the six months ended 28 February 2022. During the period, DGN delivered an NAV total return of -7.7% in sterling terms, outperforming the -8.1% fall in the benchmark, the MSCI AC Asia Pacific (ex Japan) Index (also in sterling […]
NextEnergy Solar Fund (NESF) has announced that it has commenced the construction of Whitecross, a 36MW, subsidy-free utility solar plant, located in Lincolnshire. The original construction date of the asset was pushed back from the second half of 2021 “due to material volatility in the solar PV module supply chain post covid which has since […]
In QuotedData’s morning briefing 8 April 2022: HydrogenOne Capital Growth (HGEN) has announced that its placing, which was previously announced on 4 April 2022, has raised gross proceeds of £21.5 million via the issue of 21,469,999 New Ordinary Shares at a price of 100 pence per New Ordinary Share. The Placing was well supported by new […]
BB Biotech (SWX:BION) showed a resilient investment performance in an extremely difficult period for biotech in the first quarter this year, although its NAV, share price and long standing premium have all clearly come under pressure. The Swiss investment company closed the first quarter of 2022 with its shares trading at CHF65.4, down by 10.3%, […]
It’s that time of year where we see a flurry of annual and interim results hitting the market for companies whose reporting periods finish on 31 December. Even in a quiet year, it is quite possible for interesting stories to get lost in this first quarter deluge, but once you factor in the additional market […]
Henderson High Income (HHI) has announced its annual results for the year ended 31 December 2021, during which it provided NAV and share price total returns of 19.8% and 27.9% respectively, exceeding the total return of its benchmark (a composite that is 80% All-Share and 20% the ICE BofAML Sterling Non-Gilts Index rebalanced annually), which […]
International Public Partnerships (INPP) has announced that it has reached financial close on Stage 3 of the Gold Coast Light Rail project. This follow-on investment has arisen through the Company’s existing 30% interest in the Project. The Project extends the existing Gold Coast Light Rail network (known as G:link) a further 6.7 kilometres south from […]
